Urman A, Schonman I, De Jesus-Acosta A
Curr Treat Options Oncol. 2025; 26(2):92-102.
PMID: 39843688
DOI: 10.1007/s11864-024-01283-4.
Fuchigami T, Nakayama T, Miyanari Y, Nozaki I, Ishikawa N, Tagawa A
Chem Biomed Imaging. 2024; 2(5):374-383.
PMID: 39474121
PMC: 11504145.
DOI: 10.1021/cbmi.4c00017.
Rida P, Baker S, Saidykhan A, Bown I, Jinna N
Cancers (Basel). 2024; 16(18).
PMID: 39335162
PMC: 11429756.
DOI: 10.3390/cancers16183191.
Wadhwa R, Wang J, Shefrin S, Zhang H, Sundar D, Kaul S
Cancers (Basel). 2024; 16(17).
PMID: 39272948
PMC: 11394585.
DOI: 10.3390/cancers16173090.
Zhu Y, Li T, Zhou S, Wang G, Zhang H, Yin Y
PLoS One. 2024; 19(8):e0309539.
PMID: 39213375
PMC: 11364297.
DOI: 10.1371/journal.pone.0309539.
CCT6A promotes cell proliferation in colon cancer by targeting BIRC5 associated with p53 status.
Zhang H, Zheng T, Qin C, Zhang X, Lin H, Huang X
Cancer Gene Ther. 2024; 31(8):1151-1163.
PMID: 38997438
DOI: 10.1038/s41417-024-00806-3.
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.
Nouri M, Varkaris A, Ridinger M, Dalrymple S, Dennehy C, Isaacs J
Mol Cancer Ther. 2024; 23(10):1404-1417.
PMID: 38894678
PMC: 11444904.
DOI: 10.1158/1535-7163.MCT-23-0933.
Transcriptome analysis of adipose tissue and muscle of Laiwu and Duroc pigs.
Wu J, Yu F, Di Z, Bian L, Yang J, Wang L
Anim Nutr. 2024; 17:134-143.
PMID: 38766520
PMC: 11101945.
DOI: 10.1016/j.aninu.2023.12.012.
Survivin as a Therapeutic Target for the Treatment of Human Cancer.
Wang Q, Greene M
Cancers (Basel). 2024; 16(9).
PMID: 38730657
PMC: 11083197.
DOI: 10.3390/cancers16091705.
FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.
Takeda K, Ohta S, Nagao M, Kobayashi E, Tago K, Funakoshi-Tago M
Int J Mol Sci. 2024; 25(7).
PMID: 38612503
PMC: 11011477.
DOI: 10.3390/ijms25073693.
Survivin in lung cancer: a potential target for therapy and prevention-a narrative review.
Pachimatla A, Fenstermaker R, Ciesielski M, Yendamuri S
Transl Lung Cancer Res. 2024; 13(2):362-374.
PMID: 38496694
PMC: 10938099.
DOI: 10.21037/tlcr-23-621.
Survivin Mediates Mitotic Onset in HeLa Cells Through Activation of the Cdk1-Cdc25B Axis.
Canovas P
Res Sq. 2024; .
PMID: 38464014
PMC: 10925418.
DOI: 10.21203/rs.3.rs-3949429/v1.
Interpretable deep learning methods for multiview learning.
Wang H, Lu H, Sun J, Safo S
BMC Bioinformatics. 2024; 25(1):69.
PMID: 38350879
PMC: 11265116.
DOI: 10.1186/s12859-024-05679-9.
Single-cell RNA sequencing analysis identifies one subpopulation of endothelial cells that proliferates and another that undergoes the endothelial-mesenchymal transition in regenerating pig hearts.
Nguyen T, Geng X, Wei Y, Ye L, Garry D, Zhang J
Front Bioeng Biotechnol. 2024; 11:1257669.
PMID: 38288246
PMC: 10823534.
DOI: 10.3389/fbioe.2023.1257669.
Therapeutic Efficacy of YM155 to Regulate an Epigenetic Enzyme in Major Subtypes of RCC.
Hong S, Lee Y, Jang E, Hwang H, Kim E, Son D
Int J Mol Sci. 2024; 25(1).
PMID: 38203388
PMC: 10779260.
DOI: 10.3390/ijms25010216.
Do Tumor SURVIVIN and MDM2 Expression Levels Correlate with Treatment Response and Clinical Outcome in Isolated Limb Perfusion for In-Transit Cutaneous Melanoma Metastases?.
Russano F, Del Fiore P, Cassalia F, Benna C, DallOlmo L, Rastrelli M
J Pers Med. 2023; 13(12).
PMID: 38138884
PMC: 10744937.
DOI: 10.3390/jpm13121657.
Pathogenetic model of survivin-dependent molecular signalling pathways in tumorigenesis of oral cancer and precursor lesions.
Aggarwal D, Shetty D, Jain A, Gulati N, Juneja S
J Oral Maxillofac Pathol. 2023; 27(2):287-294.
PMID: 37854918
PMC: 10581315.
DOI: 10.4103/jomfp.jomfp_5_23.
Caspase-mediated nuclear pore complex trimming in cell differentiation and endoplasmic reticulum stress.
Cho U, Hetzer M
Elife. 2023; 12.
PMID: 37665327
PMC: 10476967.
DOI: 10.7554/eLife.89066.
An In Silico Study Investigating Camptothecin-Analog Interaction with Human Protein Tyrosine Phosphatase, SHP2 (PTPN11).
Bajia D, Derwich K
Pharmaceuticals (Basel). 2023; 16(7).
PMID: 37513838
PMC: 10386118.
DOI: 10.3390/ph16070926.
In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer.
Chen L, Mokgautsi N, Kuo Y, Wu A, Huang H
Biomedicines. 2023; 11(7).
PMID: 37509650
PMC: 10376976.
DOI: 10.3390/biomedicines11072011.